Last reviewed · How we verify
Anti-scorpion venom serum Alacramyn
Anti-scorpion venom serum Alacramyn is a Antivenom serum Biologic drug developed by Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.. It is currently in Phase 3 development for Scorpion envenomation (Centruroides species and related scorpion stings). Also known as: antiscorpion venom serum.
Alacramyn is an antivenom serum that neutralizes scorpion venom toxins through specific antibodies that bind to and inactivate venom components.
Alacramyn is an antivenom serum that neutralizes scorpion venom toxins through specific antibodies that bind to and inactivate venom components. Used for Scorpion envenomation (Centruroides species and related scorpion stings).
At a glance
| Generic name | Anti-scorpion venom serum Alacramyn |
|---|---|
| Also known as | antiscorpion venom serum |
| Sponsor | Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. |
| Drug class | Antivenom serum |
| Modality | Biologic |
| Therapeutic area | Toxicology / Emergency Medicine |
| Phase | Phase 3 |
Mechanism of action
The serum contains polyclonal antibodies raised against scorpion venom that bind to and neutralize the active toxins responsible for systemic envenomation effects. These antibodies prevent venom toxins from interacting with cellular targets, thereby reducing the severity of symptoms and complications from scorpion stings. The mechanism is passive immunization, providing immediate neutralization of circulating venom.
Approved indications
- Scorpion envenomation (Centruroides species and related scorpion stings)
Common side effects
- Serum sickness
- Hypersensitivity reactions
- Anaphylaxis
Key clinical trials
- Decrease in Temperature as a Pagtonomic Sign by Scorpion Sting
- Randomized Controlled Trial to Compare Two Anti-scorpion Serums (PHASE4)
- Compare Two Anti-Scorpion Venom Serum In Children (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anti-scorpion venom serum Alacramyn CI brief — competitive landscape report
- Anti-scorpion venom serum Alacramyn updates RSS · CI watch RSS
- Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. portfolio CI
Frequently asked questions about Anti-scorpion venom serum Alacramyn
What is Anti-scorpion venom serum Alacramyn?
How does Anti-scorpion venom serum Alacramyn work?
What is Anti-scorpion venom serum Alacramyn used for?
Who makes Anti-scorpion venom serum Alacramyn?
Is Anti-scorpion venom serum Alacramyn also known as anything else?
What drug class is Anti-scorpion venom serum Alacramyn in?
What development phase is Anti-scorpion venom serum Alacramyn in?
What are the side effects of Anti-scorpion venom serum Alacramyn?
Related
- Drug class: All Antivenom serum drugs
- Manufacturer: Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. — full pipeline
- Therapeutic area: All drugs in Toxicology / Emergency Medicine
- Indication: Drugs for Scorpion envenomation (Centruroides species and related scorpion stings)
- Also known as: antiscorpion venom serum
- Compare: Anti-scorpion venom serum Alacramyn vs similar drugs
- Pricing: Anti-scorpion venom serum Alacramyn cost, discount & access